What is Faslodex® ? (fulvestrant)
Faslodex is an estrogen receptor antagonist used to treat certain cases of hormone receptor positive (HR+) advanced or metastatic breast cancer. It is approved to treat: 1,2
- HR+, human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer in women who are postmenopausal and have not been previously treated with endocrine therapy
- HR+ advanced breast cancer in women who are postmenopausal and whose disease has progressed after treatment with other endocrine therapy
- HR+, HER2- advanced breast cancer or breast cancer that has metastasized (spread to other parts of the body) in combination with abemaciclib or palbociclib in women whose disease has progressed after treatment with other endocrine therapy
- HR+, HER2- advanced breast cancer or breast cancer that has metastasized (spread to other parts of the body) in women who are postmenopausal, in combination with ribociclib as initial endocrine therapy or in women whose disease has progressed after treatment with other endocrine therapy
Fulvestrant is manufactured by AstraZeneca.
What is the ingredient in Faslodex?
The active ingredient in Faslodex is fulvestrant, an estrogen receptor antagonist.1
How does fulvestrant work?
Many breast cancers have estrogen receptors on the surface of their cells. Estrogen can connect to these receptors and stimulate the growth of these breast cancers. Fulvestrant binds to the estrogen receptor and can help block or slow the breast cancer’s growth.1
What are some of the possible side effects of fulvestrant?
In some people, fulvestrant may cause a hypersensitivity reaction (severe allergic reaction), potentially causing itching, hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.2
Fulvestrant may cause nerve damage where it is injected (in the buttocks), which may cause numbness, tingling, and/or weakness in the legs. These symptoms should be reported to a healthcare professional.2
These are not all the possible side effects of fulvestrant. Patients should talk to their doctor about what to expect with treatment with fulvestrant.
Things to know about fulvestrant
Before starting treatment with fulvestrant, patients should discuss with their doctor all their health conditions, especially:2
Fulvestrant may cause harm to an unborn baby and should not be used by women who are pregnant. Women who can become pregnant should use effective contraception during fulvestrant treatment and for at least one year after their final dose (patients should discuss appropriate birth control methods with their doctor).2
It is not known if fulvestrant can pass into breastmilk. Women should not breastfeed during treatment with fulvestrant and for at least one year after their final dose of fulvestrant.2
Before starting treatment with fulvestrant, patients should talk to their doctor about all their medications (prescription and over-the-counter), herbal supplements, and vitamins they are taking. Some medications or supplements may interfere with each other and may cause side effects..2
Fulvestrant is given as an intramuscular (into the muscle) injection into the buttocks. Your doctor will determine the appropriate fulvestrant dosing regimen and administration schedule for you. 1
For more information, read the full prescribing information of fulvestrant.
Patients should talk to their doctor if they have any questions, or if they have questions regarding their fulvestrant regimen.